TEL AVIV, Israel (AP) _ Galmed Pharmaceuticals Ltd. (GLMD) on Wednesday reported a loss of $5.4 million in its third quarter.

On a per-share basis, the Tel Aviv, Israel-based company said it had a loss of 21 cents.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLMD at https://www.zacks.com/ap/GLMD

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News